Geode Capital Management LLC increased its stake in Milestone Scientific Inc. (NYSE:MLSS – Free Report) by 6.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 527,005 shares of the company’s stock after buying an additional 31,572 shares during the quarter. Geode Capital Management LLC owned about 0.68% of Milestone Scientific worth $480,000 as of its most recent SEC filing.
Separately, Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific in the third quarter worth approximately $48,000. Institutional investors own 5.79% of the company’s stock.
Milestone Scientific Price Performance
Milestone Scientific stock opened at $1.18 on Monday. The stock has a market cap of $91.91 million, a price-to-earnings ratio of -16.85 and a beta of 1.10. The firm has a 50-day moving average of $0.86 and a two-hundred day moving average of $0.89. Milestone Scientific Inc. has a 1 year low of $0.54 and a 1 year high of $1.27.
Insider Activity at Milestone Scientific
Wall Street Analyst Weigh In
MLSS has been the subject of a number of recent analyst reports. Benchmark restated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com assumed coverage on Milestone Scientific in a research report on Monday. They set a “hold” rating for the company.
View Our Latest Analysis on Milestone Scientific
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- What is the Shanghai Stock Exchange Composite Index?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- The 3 Best Blue-Chip Stocks to Buy Now
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Want to see what other hedge funds are holding MLSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Milestone Scientific Inc. (NYSE:MLSS – Free Report).
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.